Depuy Synthes Products, Inc.

Ethicon, Gmbh

Advanced Technologies and Regenerative Medicine, LLC

Johnson & Johnson Consumer Inc.

Janssen Pharmaceutica Nv

Ethicon Endo-surgery, Inc.

Cordis Corporation

Depuy Mitek, Inc.

Anna Gosiewska

Alexander M Harmon

Anthony J Kihm

Agnieszka Seyda

Ian Ross Harris

Darin J Messina

Sanjay Mistry

Chin-Feng Yi

Sridevi N Dhanaraj

David C Colter

Charito S Buensuceso

Laura Brown

Jean Xu

Ying Sun

Jeffrey M Wu

L S Klaudyne Hong

Christian C Kazanecki

Dennis D Jamiolkowski

Julia Hwang

Francois Binette

Brian C Kramer

Kevin L Cooper

George A Heavner

Angelo G Scopelianos

Jeffrey C Geesin

Khalid Mahmood

Chunlin Yang

Murty Narayan Vyakarnam

Iksoo Chun

Aruna Nathan

Mark C Zimmerman

Raymond S Shissias

Michael J Romanko

Robert D Gordon

Jeffrey R Yon

Josiena J H Dijkmans

Susan Roweton

Nikoleta Batchvarova

Carrie H Fang

Christine K Ward

Gabriela Oana Cula

Ziwei Wang

Robert Gordon

Jeff Yon

Jörg J Sprengel

Ali Rezania

Xuanhan Lin

J&ouml;rg J Sprengel

Anuli Anyanwu-Ofili

Robert Boland

Antonius P J Van Den Heuvel

Carri H Fang

Klaudyne L S Hong

Mary F Panozzo

James J Ward

Donald Christopher Marsden

Dhanaraj Sridevi

Laura J Brown

Ls Klaudyne Hong

Thoppil Mathew John

David Colter

Klaudyne L Hong

Use of an artificial intelligence engine to provide skin care treatment is disclosed.

Use of artificial intelligence to identify novel targets and methodologies for skin care treatment

Cells derived from postpartum tissue and methods for their isolation and induction to differentiate to cells of a chondrogenic or osteogenic phenotype are provided by the invention. The invention further provides cultures and compositions of the postpartum-derived cells and products related thereto. The postpartum-derived cells of the invention and products related thereto have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications, for example, in the treatment of bone and cartilage conditions.

Cartilage and bone repair and regeneration using postpartum-derived cells

Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.

Postpartum cells derived from placental tissue, and methods of making and using the same

This invention provides for compositions for cryopreservation of human umbilical cord tissue-derived cells. The cryopreservation compositions may comprise: (a) amino acids; (b) vitamins; (c) inorganic salts; and (d) DMSO, sucrose, mannitol, and lactobionic acid. The invention also provides for kits comprising the composition and human umbilical cord tissue-derived cells and methods of cryopreserving the cells, which utilize the compositions.

Composition and methods for cryopreservation of hUTC

Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.

Soft tissue repair and regeneration using postpartum-derived cells and cell products

A biocompatible tissue repair implant or scaffold device is provided for use in repairing a variety of tissue injuries, particularly injuries to cartilage, ligaments, tendons, and nerves. The repair procedures may be conducted with implants that contain a biological component that assists in healing or tissue repair. The biocompatible tissue repair implants include a biocompatible scaffold and particles of living tissue, such that the tissue and the scaffold become associated. The particles of living tissue contain one or more viable cells that can migrate from the tissue and populate the scaffold.

Biocompatible scaffolds with tissue fragments

Compositions and methods of using cells derived from umbilical cord tissue to stimulate and support lung tissue angiogenesis, to improve blood flow to lung tissue, to regenerate, repair, and improve lung tissue damaged by lung disease, disorder and/or injury, and to protect lung tissue from damage caused by lung disease, disorder and/or injury in a patient.

Treatment of lung and pulmonary diseases and disorders

Isolated or purified mammalian kidney-derived cell populations from mammalian kidney tissue are provided. Methods are provided for the isolation and purification of the mammalian kidney-derived cell population. Methods for treating kidney disease are provided by administration of the isolated or purified mammalian kidney-derived cell population to a mammalian subject.

Kidney-derived cells and methods of use in tissue repair and regeneration

Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.

Topical gel compositions including polycaprolactone polymer and methods for enhancing the topical application of a benefit agent

Growing community of inventors

Skillman, NJ, United States of America

Anna Gosiewska